Shinva Medical Instrument Co Ltd

SHG:600587 China Medical Devices
Market Cap
$1.27 Billion
CN¥9.30 Billion CNY
Market Cap Rank
#7997 Global
#1451 in China
Share Price
CN¥15.33
Change (1 day)
+0.20%
52-Week Range
CN¥14.40 - CN¥18.14
All Time High
CN¥38.58
About

Shinva Medical Instrument Co.,Ltd. provides medical devices, pharmaceutical equipment, medical services, and medical trade in the People's Republic of China. The company offers medical devices, including infection control instruments such as washing disinfection, sterilization, and consumables; radiotherapy equipment; and surgical instruments and biomedical consumables comprising standard, neuro,… Read more

Shinva Medical Instrument Co Ltd (600587) - Net Assets

Latest net assets as of September 2025: CN¥8.16 Billion CNY

Based on the latest financial reports, Shinva Medical Instrument Co Ltd (600587) has net assets worth CN¥8.16 Billion CNY as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥15.08 Billion) and total liabilities (CN¥6.91 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥8.16 Billion
% of Total Assets 54.15%
Annual Growth Rate 21.78%
5-Year Change 64.32%
10-Year Change 101.21%
Growth Volatility 46.33

Shinva Medical Instrument Co Ltd - Net Assets Trend (1999–2024)

This chart illustrates how Shinva Medical Instrument Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Shinva Medical Instrument Co Ltd (1999–2024)

The table below shows the annual net assets of Shinva Medical Instrument Co Ltd from 1999 to 2024.

Year Net Assets Change
2024-12-31 CN¥7.98 Billion +3.40%
2023-12-31 CN¥7.72 Billion +33.35%
2022-12-31 CN¥5.79 Billion +9.89%
2021-12-31 CN¥5.27 Billion +8.45%
2020-12-31 CN¥4.86 Billion +3.52%
2019-12-31 CN¥4.69 Billion +12.76%
2018-12-31 CN¥4.16 Billion +0.88%
2017-12-31 CN¥4.13 Billion +2.67%
2016-12-31 CN¥4.02 Billion +1.28%
2015-12-31 CN¥3.97 Billion +14.88%
2014-12-31 CN¥3.45 Billion +26.84%
2013-12-31 CN¥2.72 Billion +67.57%
2012-12-31 CN¥1.62 Billion +86.51%
2011-12-31 CN¥871.17 Million +12.11%
2010-12-31 CN¥777.06 Million +9.43%
2009-12-31 CN¥710.12 Million +8.23%
2008-12-31 CN¥656.12 Million +4.46%
2007-12-31 CN¥628.10 Million +71.76%
2006-12-31 CN¥365.69 Million +6.00%
2005-12-31 CN¥344.98 Million +4.99%
2004-12-31 CN¥328.57 Million -1.62%
2003-12-31 CN¥333.97 Million +13.51%
2002-12-31 CN¥294.23 Million +224.58%
2001-12-31 CN¥90.65 Million +30.07%
2000-12-31 CN¥69.69 Million +20.34%
1999-12-31 CN¥57.91 Million --

Equity Component Analysis

This analysis shows how different components contribute to Shinva Medical Instrument Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 54892.6% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings CN¥3.92 Billion 51.65%
Common Stock CN¥606.68 Million 7.99%
Other Components CN¥3.07 Billion 40.36%
Total Equity CN¥7.60 Billion 100.00%

Shinva Medical Instrument Co Ltd Competitors by Market Cap

The table below lists competitors of Shinva Medical Instrument Co Ltd ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Shinva Medical Instrument Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 7,318,625,200 to 7,597,127,229, a change of 278,502,029 (3.8%).
  • Net income of 691,609,561 contributed positively to equity growth.
  • Dividend payments of 329,034,516 reduced retained earnings.
  • Share repurchases of 75,070 reduced equity.
  • Other factors decreased equity by 83,997,946.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CN¥691.61 Million +9.1%
Dividends Paid CN¥329.03 Million -4.33%
Share Repurchases CN¥75.07K -0.0%
Other Changes CN¥-84.00 Million -1.11%
Total Change CN¥- 3.81%

Book Value vs Market Value Analysis

This analysis compares Shinva Medical Instrument Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.22x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 57.55x to 1.22x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1999-12-31 CN¥0.27 CN¥15.33 x
2000-12-31 CN¥0.32 CN¥15.33 x
2001-12-31 CN¥0.42 CN¥15.33 x
2002-12-31 CN¥1.35 CN¥15.33 x
2003-12-31 CN¥1.47 CN¥15.33 x
2004-12-31 CN¥1.33 CN¥15.33 x
2005-12-31 CN¥1.40 CN¥15.33 x
2006-12-31 CN¥1.71 CN¥15.33 x
2007-12-31 CN¥2.11 CN¥15.33 x
2008-12-31 CN¥2.03 CN¥15.33 x
2009-12-31 CN¥2.19 CN¥15.33 x
2010-12-31 CN¥2.33 CN¥15.33 x
2011-12-31 CN¥2.65 CN¥15.33 x
2012-12-31 CN¥4.44 CN¥15.33 x
2013-12-31 CN¥6.67 CN¥15.33 x
2014-12-31 CN¥7.32 CN¥15.33 x
2015-12-31 CN¥7.95 CN¥15.33 x
2016-12-31 CN¥8.45 CN¥15.33 x
2017-12-31 CN¥8.05 CN¥15.33 x
2018-12-31 CN¥8.70 CN¥15.33 x
2019-12-31 CN¥10.28 CN¥15.33 x
2020-12-31 CN¥10.79 CN¥15.33 x
2021-12-31 CN¥12.09 CN¥15.33 x
2022-12-31 CN¥13.27 CN¥15.33 x
2023-12-31 CN¥12.31 CN¥15.33 x
2024-12-31 CN¥12.52 CN¥15.33 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Shinva Medical Instrument Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 9.10%
  • The company has moderate efficiency in generating returns from equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 6.90%
  • • Asset Turnover: 0.65x
  • • Equity Multiplier: 2.04x
  • Recent ROE (9.10%) is above the historical average (8.23%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1999 14.14% 11.21% 0.63x 2.01x CN¥2.40 Million
2000 16.86% 8.92% 0.73x 2.60x CN¥4.78 Million
2001 20.57% 10.36% 0.64x 3.12x CN¥9.58 Million
2002 7.26% 8.56% 0.47x 1.80x CN¥-8.06 Million
2003 7.55% 8.74% 0.47x 1.82x CN¥-7.80 Million
2004 -9.94% -9.62% 0.41x 2.49x CN¥-57.79 Million
2005 4.95% 3.64% 0.54x 2.53x CN¥-15.42 Million
2006 6.57% 4.40% 0.57x 2.60x CN¥-11.09 Million
2007 3.83% 4.24% 0.52x 1.73x CN¥-36.10 Million
2008 4.86% 4.56% 0.65x 1.65x CN¥-31.65 Million
2009 6.35% 4.66% 0.86x 1.59x CN¥-23.68 Million
2010 8.66% 4.50% 0.90x 2.14x CN¥-9.35 Million
2011 13.59% 5.09% 1.08x 2.47x CN¥28.36 Million
2012 11.05% 5.38% 0.90x 2.29x CN¥15.48 Million
2013 9.60% 5.52% 0.78x 2.23x CN¥-9.63 Million
2014 11.20% 5.20% 0.78x 2.77x CN¥35.02 Million
2015 8.68% 3.72% 0.77x 3.03x CN¥-42.88 Million
2016 1.07% 0.41% 0.74x 3.50x CN¥-290.51 Million
2017 1.99% 0.66% 0.80x 3.77x CN¥-264.30 Million
2018 0.69% 0.22% 0.83x 3.75x CN¥-307.74 Million
2019 20.61% 9.82% 0.76x 2.78x CN¥443.38 Million
2020 5.34% 2.56% 0.79x 2.64x CN¥-204.32 Million
2021 11.32% 5.87% 0.82x 2.36x CN¥65.02 Million
2022 9.27% 5.39% 0.72x 2.40x CN¥-39.24 Million
2023 8.94% 6.53% 0.64x 2.13x CN¥-77.87 Million
2024 9.10% 6.90% 0.65x 2.04x CN¥-68.10 Million

Industry Comparison

This section compares Shinva Medical Instrument Co Ltd's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $1,879,733,462
  • Average return on equity (ROE) among peers: 24.67%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Shinva Medical Instrument Co Ltd (600587) CN¥8.16 Billion 14.14% 0.85x $845.00 Million
Shanghai Kehua Bio-Engineering Co Ltd (002022) $792.82 Million 25.77% 0.17x $318.98 Million
Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223) $482.51 Million 20.84% 0.32x $2.79 Billion
Double Medical Technology Inc (002901) $224.61 Million 43.10% 0.32x $404.40 Million
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) $1.42 Million 98.49% 2.27x $281.14 Million
Lepu Medical Tech Beijing (300003) $12.27 Billion 14.01% 0.69x $2.71 Billion
INKON Life Technology Co Ltd (300143) $1.81 Billion -20.17% 0.37x $637.77 Million
Edan Instruments Inc (300206) $1.26 Billion 7.37% 0.15x $501.55 Million
Guangdong Biolight Meditech Co Ltd (300246) $504.27 Million 13.31% 0.36x $360.97 Million
Beijing Leadman Biochemistry Co Ltd (300289) $1.44 Billion 2.82% 0.20x $267.10 Million
Sinocare Inc (300298) $17.42 Million 41.15% 0.68x $952.60 Million